Table 1.
Full-term | Very preterm | Late preterm | |||
---|---|---|---|---|---|
Number of participants | 15 | 10 | 8 | ||
Female | 6 | 5 | 3 | ||
Gestational age at birth (weeks) | 38.2 (36.1–41.0) | 29.0 (27.1–31.4) | 34.7 (34–35.7) | ||
Birthweight (g) | 3166 (2130–4590) | 1173 (760–1900) | 2449 (1550–4525) | ||
Antenatal factors | |||||
Prolonged rupture of membranes | 1 | 5 | 2 | ||
Intrauterine growth restriction (IUGR)1 | 1 | 3 | 2 | ||
Abnormal Doppler | 0 | 1 | 1 | ||
Maternal infection (Chorioamnionitis) | 0 | 4 | 0 | ||
Delivery | |||||
Vaginal (assisted/unassisted) | 8 | 2 | 5 | ||
Caesarean | 7 | 8 | 3 | ||
Apgar score at 10 mins | 10 | 9 (8–10) | 9.75 (8–10) | ||
Conditions during admission in NICU | |||||
Neurological conditions | 0 | 1* | 0 | ||
Cardiac conditions | 0 | 1** | 0 | ||
Respiratory distress syndrome | 1 | 7 | 1 | ||
Invasive mechanical ventilation < 24 hrs | 0 | 2 | 3 | ||
Invasive mechanical ventilation > 24 hrs | 0 | 2*** | 0 | ||
Infection suspected | 1 | 4 | 2 | ||
Previous surgery | 0 | 0 | 0 | ||
Test occasion | <32 | 32–34 | 34–37 | ||
Postmenstrual age at study (weeks) | 38.5 (36.6–41.7) | 30.4 (28–31.9) | 32.7 (32–33.3) | 35.1 (34.3–36.3) | 35.5 (34.7–36.4) |
Postnatal age at study (days) | 3.7 (1–7) | 9.8 (5–15) | 23.6 (15–36) | 44 (36–58) | 5.9 (4–10) |
Respiratory support (LFT/HFT) at study | 0 | 5 | 5 | 4 | 0 |
Non-standard drugs2at study – Budesonide | 0 | 0 | 1 | 1 | 0 |
Analgesics < 24 hrs prior to study | 0 | 0 | 0 | 0 | 0 |
Antibiotics at study | 1 | 1 | 0 | 0 | 0 |
Prior pain | 2 (0–23) | 21.3 (11–46) | 33.9 (22–59) | 37.5 (25–65) | 10 (3–21) |
* Choroid plexus cyst.
** Patent ductus arteriosus (PDA).
*** Infants were ventilated for a maximum of 4 days and did not require further periods of ventilation.
LFT = Oxygen therapy.
HFT = High flow nasal cannulae.
Prior pain = number of skin breaking procedures and endotracheal tube/oral suction.
For age, birthweight, and prior pain, values are presented as means (accumulative mean for prior pain) with range in parentheses.
IUGR is defined as any baby whose weight is below the 10th percentile for their gestational age.
Standard drugs include: Caffeine citrate, Vitamins, Probiotics, Breast milk fortifier, Iron, Sodium and Phosphate supplements.